Validation of a French Version of the Confusion Assessment Method (CAM)

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Completed
CT.gov ID
NCT01775982
Collaborator
(none)
102
8
22.1
12.8
0.6

Study Details

Study Description

Brief Summary

To validate the French version of the CAM, a multicenter diagnostic study will be conducted. The principle of this study is identical to the study of Inouye which initially validated the CAM in 1990. This is to verify the diagnostic properties of the CAM (French version) compared to the gold standard represented by the confused state of psychiatric diagnosis using the DSM.

A representative sample of geriatric patients for whom a delirium is suspected, will be recruited in the various participating centers, patients will undergo two consecutive visits:

  • A visit by a geriatrician, during which the confused state of the patient will be evaluated using the French version of the CAM.

  • A visit by a psychiatrist during which the diagnosis of confusional state will be evaluated using the gold standard criteria of the DSM IV.

These two evaluations will be conducted on the same day and blinded from each other.

The order of these two procedures will be balanced within each center. This process will allow the calculation of diagnostic parameters of the CAM French version (validation competitive): sensitivity, specificity, positive and negative predictive values .

Condition or Disease Intervention/Treatment Phase
  • Other: Psychiatric evaluation
  • Other: Geriatric evaluation

Study Design

Study Type:
Observational
Actual Enrollment :
102 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Validation of a French Version of the Confusion Assessment Method (CAM): a Diagnostic Tool for Acute Confusion Among the Elderly
Study Start Date :
Apr 1, 2014
Actual Primary Completion Date :
Feb 2, 2016
Actual Study Completion Date :
Feb 2, 2016

Arms and Interventions

Arm Intervention/Treatment
Study population

See inclusion and exclusion criteria. Intervention: Psychiatric evaluation Intervention: Geriatric evaluation A potential intervention order effect will be taken into account by balancing in each center the number of evaluations beginning with the geriatric assessment and those starting with the psychiatric assessment.

Other: Psychiatric evaluation
This evaluation is carried out in several stages: Assessment of cognitive functioning; Interview with a relative; Interview with caregivers; Evaluation of the presence of delirium according to DSM-IV criteria; Evaluation of the presence of anxiety, depressive syndrome, dementia or other DSM IV; Reports of adverse events. A potential intervention order effect will be taken into account by balancing in each center the number of evaluations beginning with the geriatric assessment and those starting with the psychiatric assessment.

Other: Geriatric evaluation
This evaluation includes a brief interview with a caregiver, diverse scorings (CAM, Delirium Index, Mini Geriatric Depression Scale, Modified Early Warning Score, Clinical Global Impression sclae, Algo Plus), and adverse event reporting. CAM scoring is carried out by a trained geriatrician and a trained nurse and/or a psychologist. A potential intervention order effect will be taken into account by balancing in each center the number of evaluations beginning with the geriatric assessment and those starting with the psychiatric assessment.

Outcome Measures

Primary Outcome Measures

  1. CAM French Version: diagnostic properties [Day 0]

    Sensitivity, specificity, positive predictive value, negative predictive value

Secondary Outcome Measures

  1. Reliability and quality of the french version of the CAM [Day 0]

    Parameters of reliability and quality of the tool: Inter-rater Agreement (measured by a coefficient of correlation) between two evaluators: geriatrician and a nurse or psychologist Internal consistency of the questionnaire assessed by calculating Cronbach's alpha Time required for assessment Acceptability by clinicians Tolerance of patients

  2. Feasibility of scoring with the French version of the Delirium Index [day 0]

  3. Diagnostic properties of alternative algorithms constructed from items of CAM (French version) [day 0]

Other Outcome Measures

  1. Patient age (years) [Baseline (day 0)]

  2. Patient weight (kg) [Baseline (Day 0)]

  3. Height (cm) [Baseline (day 0)]

  4. Education level [baseline (day 0)]

    primary, secondary, or higher

  5. Living situation (qualitative) [baseline (day 0)]

    Does the patient live at home? or is the patient institutionalized?

  6. Presence/absence of a caregiver [baseline (day 0)]

  7. Hospitalization within the past 3 months? yes/no [baseline (day 0)]

  8. Has the patient fallen within the past year? yes/no [baseline (day 0)]

  9. presence/absence of a visual or hearing impairment [baseline (day 0)]

  10. patient position during evaluation [baseline (day 0)]

    qualitative variable: in bed, in a wheelchair, sitting down

  11. ADL (Activities of Daily Living) score for the 15 days preceding inclusion [baseline (day 0)]

  12. IADL (Instrumental Activities of Daily Living) score for the 15 days preceding inclusion [baseline (day 0)]

  13. ADL (Activities of Daily Living) score at the moment of inclusion [baseline (day 0)]

  14. Clinical and para-clinical examination [baseline (day 0)]

  15. Evaluation of the patient's physiological state [baseline (day 0)]

  16. Diagnosis [baseline (day 0)]

  17. Prescribed drugs [baseline (day 0)]

  18. Comorbidities (Charlson score) [baseline (day 0)]

  19. History of dementia, depression or another psychiatric disorder [baseline (day 0)]

    Notification in the patient's history of dementia, depression or another psychiatric disorder, assessed by NPI-R and Mini GDS.

  20. Severity of clinical condition [baseline (day 0)]

    Severity of clinical condition: MEWS (Subbe CP et al, 2001) and CGI (Guy W 1976) + Charlson scale

  21. Presence or absence of dementia before admission [baseline (day 0)]

    Presence or absence of dementia before admission (IQCODE French version) (Jorm AF 1994 and Law S, 1995)

Eligibility Criteria

Criteria

Ages Eligible for Study:
75 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • A family member of the patient, or his/her "trusted person" must have given his/her informed and signed consent

  • The patient must be insured or beneficiary of a health insurance plan

  • Hospitalization in geriatric short stay OR patient consulting at a geriatric assessment center / memory clinic OR geriatric day hospitalization

  • Patients for whom a state of confusion is suspected during the pre-inclusion visit run-in based on the following criteria:

  • Presence of a cognitive function disorder as defined by a score greater than or equal to 3 on the Short Portable Mental Status Questionnaire (SPMSQ) (Pfeiffer E, 1975) AND / OR

  • Presence of a mood disorder and / or behavior disorder (regardless of duration) according to the patient's family or caregivers

  • Presence of a caregiver who can answer questionnaires concerning activities of everyday life

Exclusion Criteria:
  • The patient is participating in another study

  • The patient is in an exclusion period determined by a previous study

  • The patient's family or "trusted-person" refuses to sign the consent

  • The patient does not understand french

  • Severe aphasia

  • Stay is < = 3 days

Contacts and Locations

Locations

Site City State Country Postal Code
1 CH d'Alès Alès France 30103
2 CHU de Rouen - Hôpital de Bois-Guillaume Bois Guillaume France 76230
3 APHP - Hôpital Charles Foix Ivry Sur Seine Cedex France 94205
4 APHM - Hôpital Sainte-Marguerite Marseille France 13274
5 CHU de Montpellier - Centre Antonin Balmes Montpellier cedex 5 France 34295
6 CHU de Nice - Hôpital de Cimiez Nice France 06003
7 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09 France 30029
8 CHU de Reims - Hôpital Maison Blanche Reims France 51092

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nīmes

Investigators

  • Principal Investigator: Valéry Antoine, MD, Centre Hospitalier Universitaire de Nîmes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nīmes
ClinicalTrials.gov Identifier:
NCT01775982
Other Study ID Numbers:
  • PHRC-N/2011/VA-04
  • 2011-A01161-40
First Posted:
Jan 25, 2013
Last Update Posted:
Feb 1, 2017
Last Verified:
Jan 1, 2017
Keywords provided by Centre Hospitalier Universitaire de Nīmes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 1, 2017